Validation of EQ-5D in patients with cervical cancer in Taiwan
- 363 Downloads
The survival rate of cervical cancer is increasing due to early diagnosis and timely treatment. As a result, the availability of a valid and reliable general HRQoL is important. The purpose of this study was to evaluate the psychometric properties of the EuroQol questionnaire (EQ-5D) in patients with cervical cancer in Taiwan.
Outpatients with cervical cancer were recruited from three medical centers across Taiwan. Test–retest reliability and ceiling effect were evaluated. Construct validity including convergent and discriminate validities were examined using the EORTC QLQ C-30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire) and the clinical indicators of the functional performance assessment using the Karnofsky Performance Scale (KPS) and disease status.
A total of 530 patients completed the questionnaire. The intraclass correlation coefficient for the EQ-5D index was 0.83, and the Cohen's kappa values for the EQ-5D dimensions ranged from 0.54 to 0.73. The EQ-5D index and VAS scores were higher for patients with a higher KPS score and disease-free status. The EQ-5D index was strongly correlated with all EORTC QLQ-C30 functioning scales.
The EQ-5D questionnaire is reliable and valid for the assessment of health-related quality of life in patients with cervical cancer in Taiwan.
KeywordsCervix neoplasm EQ-5D EORTC QLQ-C30 Quality of life Taiwan
This study was funded by grant no. NHRI-EX90-9007PC from the Taiwan National Health Research Institute. We are grateful to Dr. Nan Luo in Singapore for his earlier discussion on data analysis. We are most grateful to Dr. Ming-Siah Yen, Dr. Siao-Fong Huang, and Dr. Wan-Yi Jian at Taipei, Taichung and Kaohsiung Veterans General Hospitals for helping design the questionnaire and for referring patients. We sincerely thank the interviewers who collected data in the three research hospitals.
- 1.Division of Statistics DOH (2005) Statistics of causes of death, health and vital statistical. In: Editor ED (ed) Book of statistics of causes of death, health and vital statistical. Department of Health, Executive Yuan, R.O.C. TaipeiGoogle Scholar
- 8.Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMedGoogle Scholar
- 9.Gold MR, Patrick DL, Torrance DG (1996) Identifying and valuing outcomes. In: Gold MR (ed) Cost-effectiveness in health and medicine. Oxford University Press, New York, pp 82–134Google Scholar
- 24.Kind P (1996) The EuroQol instrument: an index of health-related quality of life. In: Spiker B (ed) Quality of life and pharmacoeconomics in clinical trials. Lippincott-Raven Publishers, Philadelphia, pp 191–201Google Scholar
- 31.Juniper EF, Gordon HG, Roman J (1996) How to develop and validate a new health-related quality of life instrument. In: Spiker B (ed) Quality of life and pharmacoeconomics in clinical trials. Lippincott-Raven Publishers, Philadelphia, pp 49–56Google Scholar
- 33.Nunnally JC, Bernstein IH (1994) Psychometric theory. McGraw-Hill, NYGoogle Scholar